The Omega-6/Omega-3 Ratio and Dementia or Cognitive Decline: A Systematic Review on Human Studies and Biological Evidence

It has been suggested that the intake of certain fatty acids may influence the risk of dementia. However, current reviews have focused only on the therapeutic effects of omega-3 fatty acids, mostly as supplements. To date, the evidence for the relevance of the omega-6/omega-3 ratio has been neglected. Therefore, we searched the databases Alois, Medline, Biosis, Embase, Cochrane Central Register of Controlled Trials, and The Cochrane Database of Systematic Reviews for “essential fatty acids” and “dementia” and aimed to conduct a comprehensive review across study types. All studies that reported on the association between the n-6/n-3 ratio and dementia or cognitive decline were selected. In the 13 animal studies we examined, the dietary n-6/n-3 ratio was shown to affect brain composition, Alzheimer's disease pathology, and behavior. Our review of the 14 studies in humans that fulfilled the selection criteria (7 prospective studies, 3 cross-sectional studies, 1 controlled trial, 3 case-control studies) provided evidence, albeit limited, supporting an association between the n-6/n-3 ratio, cognitive decline, and incidence of dementia. This review supports growing evidence of a positive association between the dietary n-6/n-3 ratio and the risk of Alzheimer's disease.

[1]  R. Egan,et al.  Prostaglandins, arachidonic acid, and inflammation. , 1980, Science.

[2]  L. Horrocks,et al.  Health benefits of docosahexaenoic acid (DHA) , 1999, Pharmacological research.

[3]  M. Tierney,et al.  Fatty acid analysis of blood plasma of patients with alzheimer's disease, other types of dementia, and cognitive impairment , 2000, Lipids.

[4]  Lars-Olof Wahlund,et al.  Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. , 2006, Archives of neurology.

[5]  J. Dyerberg,et al.  Plasma lipid and lipoprotein pattern in Greenlandic West-coast Eskimos. , 1971, Lancet.

[6]  H. Soininen,et al.  Fat Intake at Midlife and Risk of Dementia and Alzheimer’s Disease: A Population-Based Study , 2006, Dementia and Geriatric Cognitive Disorders.

[7]  K. Yaffe,et al.  Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association , 2009, Nature Clinical Practice Neurology.

[8]  P. Barberger‐Gateau,et al.  Adherence to a Mediterranean diet and plasma fatty acids: data from the Bordeaux sample of the Three-City study , 2011, British Journal of Nutrition.

[9]  U. Das.  A defect in the activity of Δ6 and Δ5 desaturases may be a factor predisposing to the development of insulin resistance syndrome , 2005 .

[10]  F. Calon,et al.  High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-β and tau pathologies in the 3xTg-AD model of Alzheimer's disease , 2009, Neuroscience.

[11]  G. Michael,et al.  Omega‐3 fatty acids reverse age‐related decreases in nuclear receptors and increase neurogenesis in old rats , 2010, Journal of neuroscience research.

[12]  Carlijn R Hooijmans,et al.  The effects of long-term omega-3 fatty acid supplementation on cognition and Alzheimer's pathology in animal models of Alzheimer's disease: a systematic review and meta-analysis. , 2012, Journal of Alzheimer's disease : JAD.

[13]  A. Blackwell,et al.  Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline , 2010, Alzheimer's & Dementia.

[14]  Y. Ishibashi,et al.  Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer's disease model rats , 2002, Journal of neurochemistry.

[15]  F. Calon,et al.  Endogenous conversion of omega-6 into omega-3 fatty acids improves neuropathology in an animal model of Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[16]  F. Calon,et al.  Dietary intake of unsaturated fatty acids modulates physiological properties of entorhinal cortex neurons in mice , 2012, Journal of neurochemistry.

[17]  A. Folsom,et al.  Plasma n-3 fatty acids and the risk of cognitive decline in older adults: the Atherosclerosis Risk in Communities Study. , 2007, The American journal of clinical nutrition.

[18]  V. Subrahmanyan,et al.  Effects of Partial Replacement of Rice, Wheat or Ragi (Eleusine coracana) by Tuber Flours on the Nutritive Value of Poor Vegetarian Diets , 1954, British Journal of Nutrition.

[19]  D. Thurman,et al.  How common are the “common” neurologic disorders? , 2007, Neurology.

[20]  K. Sugioka,et al.  Chronic administration of docosahexaenoic acid improves reference memory-related learning ability in young rats , 1999, Neuroscience.

[21]  K. Beyreuther,et al.  Additive effects of fatty acid mixtures on the levels and ratio of amyloid β40/42 peptides differ from the effects of individual fatty acids , 2011, Journal of Neuroscience Research.

[22]  Robert A. Lewis,et al.  Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. , 1990, The New England journal of medicine.

[23]  D. Michaelson,et al.  The isoform-specific pathological effects of apoE4 in vivo are prevented by a fish oil (DHA) diet and are modified by cholesterol. , 2012, Journal of Alzheimer's disease : JAD.

[24]  Tina L. Huang.  Omega-3 fatty acids, cognitive decline, and Alzheimer's disease: a critical review and evaluation of the literature. , 2010, Journal of Alzheimer's disease : JAD.

[25]  P. Lipsky,et al.  Cyclooxygenase in biology and disease , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[26]  J. Ibrahim,et al.  n–3 Fatty acids, hypertension and risk of cognitive decline among older adults in the Atherosclerosis Risk in Communities (ARIC) study , 2008, Public Health Nutrition.

[27]  S. Rapoport,et al.  Dietary n-6 PUFA deprivation downregulates arachidonate but upregulates docosahexaenoate metabolizing enzymes in rat brain. , 2011, Biochimica et biophysica acta.

[28]  P. Barberger‐Gateau,et al.  Low plasma eicosapentaenoic acid and depressive symptomatology are independent predictors of dementia risk. , 2008, The American journal of clinical nutrition.

[29]  H. Okuyama,et al.  Reversibility of n-3 fatty acid deficiency-induced alterations of learning behavior in the rat: level of n-6 fatty acids as another critical factor. , 2001, Journal of lipid research.

[30]  M. Piciotti,et al.  Δ6 desaturase in brain and liver during development and aging , 1990, Lipids.

[31]  L. Puskás,et al.  Effects of dietary omega-3 polyunsaturated fatty acids on brain gene expression. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Marcus Richards,et al.  Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial. , 2010, The American journal of clinical nutrition.

[33]  G. D. Paolo,et al.  Linking lipids to Alzheimer's disease: cholesterol and beyond , 2011, Nature Reviews Neuroscience.

[34]  B. Popkin,et al.  The nutrition transition: worldwide obesity dynamics and their determinants , 2004, International Journal of Obesity.

[35]  Shih-Yi Huang,et al.  The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: A preliminary randomized double-blind placebo-controlled study , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[36]  E. Feskens,et al.  Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men. , 1997, American journal of epidemiology.

[37]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[38]  Christine Van Broeckhoven,et al.  Molecular genetics of Alzheimer's disease: An update , 2008, Annals of medicine.

[39]  Takashi Morihara,et al.  A Diet Enriched with the Omega-3 Fatty Acid Docosahexaenoic Acid Reduces Amyloid Burden in an Aged Alzheimer Mouse Model , 2005, The Journal of Neuroscience.

[40]  Noriyuki Matsukawa,et al.  Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction , 2006, Neuroscience Research.

[41]  H. Tanila,et al.  Changes in cerebral blood volume and amyloid pathology in aged Alzheimer APP/PS1 mice on a docosahexaenoic acid (DHA) diet or cholesterol enriched Typical Western Diet (TWD) , 2007, Neurobiology of Disease.

[42]  K. Austen,et al.  Cytosolic phospholipase A2 is essential for both the immediate and the delayed phases of eicosanoid generation in mouse bone marrow-derived mast cells , 1999 .

[43]  B. McGuinness,et al.  Inflammation and Anti-Inflammatory Strategies for Alzheimer’s Disease – A Mini-Review , 2009, Gerontology.

[44]  Peter F Surai,et al.  Designer eggs: from improvement of egg composition to functional food , 2001 .

[45]  A. Simopoulos,et al.  Essential fatty acids in health and chronic disease. , 1999, The American journal of clinical nutrition.

[46]  L. Mucke,et al.  Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease , 2008, Nature Neuroscience.

[47]  Karen Ritchie,et al.  Long-term association of food and nutrient intakes with cognitive and functional decline: a 13-year follow-up study of elderly French women , 2009, British Journal of Nutrition.

[48]  C. Hammen.  Stress and depression. , 2005, Annual review of clinical psychology.

[49]  William M. Reynolds,et al.  Handbook of depression in children and adolescents , 1994 .

[50]  Nicolas G. Bazan,et al.  Neuroprotectin D1 Induces Neuronal Survival and Downregulation of Amyloidogenic Processing in Alzheimer’s Disease Cellular Models , 2011, Molecular Neurobiology.

[51]  Manabu T. Nakamura,et al.  Structure, function, and dietary regulation of delta6, delta5, and delta9 desaturases. , 2004, Annual review of nutrition.

[52]  A. Simopoulos.  New products from the agri-food industry: The return of n-3 fatty acids into the food supply , 2007, Lipids.

[53]  L. Zahn,et al.  FAO Food and Nutrition Paper 3: Dietary Fats and Oils in Human Nutrition. VII und 94 Seiten, 5 Abb., 18 Tab., tabell. Anhang. Food and Agriculture Organization of the United Nations, Rome 1977 , 1979 .

[54]  Johanna Kuusisto,et al.  Association between features of the insulin resistance syndrome and alzheimer's disease independently of apolipoprotein e4 phenotype: cross sectional population based study , 1997, BMJ.

[55]  S. Rapoport,et al.  Dietary n-3 PUFA deprivation alters expression of enzymes of the arachidonic and docosahexaenoic acid cascades in rat frontal cortex , 2007, Molecular Psychiatry.

[56]  Victoria J. Bourne,et al.  n-3 Fatty acid erythrocyte membrane content, APOE varepsilon4, and cognitive variation: an observational follow-up study in late adulthood. , 2008, The American journal of clinical nutrition.

[57]  A. Simopoulos,et al.  The Importance of the Omega-6/Omega-3 Fatty Acid Ratio in Cardiovascular Disease and Other Chronic Diseases , 2008, Experimental biology and medicine.

[58]  P. Barberger‐Gateau,et al.  Epidemiological studies on cognition and the omega-6/omega-3 balance. , 2011, World review of nutrition and dietetics.

[59]  T. Starzl,et al.  Generation of cloned transgenic pigs rich in omega-3 fatty acids , 2006, Nature Biotechnology.

[60]  H. Brodaty,et al.  ALZHEIMER'S DISEASE INTERNATIONAL , 1997, International journal of geriatric psychiatry.

[61]  T. Sanders.  Polyunsaturated fatty acids in the food chain in Europe. , 2000, The American journal of clinical nutrition.

[62]  S. Rapoport,et al.  Disturbed choline plasmalogen and phospholipid fatty acid concentrations in Alzheimer's disease prefrontal cortex. , 2011, Journal of Alzheimer's disease : JAD.

[63]  B. Holub,et al.  Docosahexaenoic acid-enriched milk. , 1998, World review of nutrition and dietetics.

[64]  L. Mucke,et al.  Phospholipase A2 and arachidonic acid in Alzheimer's disease. , 2010, Biochimica et biophysica acta.

[65]  B. Heude,et al.  Cognitive decline and fatty acid composition of erythrocyte membranes--The EVA Study. , 2003, The American journal of clinical nutrition.

[66]  Á. M. Patterson,et al.  The relationship between dietary lipids and cognitive performance in an elderly population , 2010, International journal of food sciences and nutrition.

[67]  B. Brooksbank,et al.  Lipid abnormalities in the brain in adult Down's syndrome and Alzheimer's disease. , 1989, Molecular and chemical neuropathology.

[68]  Suzanne Craft,et al.  Insulin resistance syndrome and Alzheimer's disease: Age- and obesity-related effects on memory, amyloid, and inflammation , 2005, Neurobiology of Aging.

[69]  A. Brand,et al.  Docosahexaenoic Acid Abundance in the Brain: A biodevice to Combat Oxidative Stress , 2002, Nutritional neuroscience.

[70]  Yaakov Stern,et al.  Food combination and Alzheimer disease risk: a protective diet. , 2010, Archives of neurology.

[71]  W. Banks,et al.  Effect of dietary n-3 polyunsaturated fatty acids on brain lipid fatty acid composition, learning ability, and memory of senescence-accelerated mouse. , 2008, The journals of gerontology. Series A, Biological sciences and medical sciences.

[72]  P. Barberger-Gateau,et al.  Dietary patterns and risk of dementia , 2007, Neurology.

[73]  F. Calon,et al.  DHA Improves Cognition and Prevents Dysfunction of Entorhinal Cortex Neurons in 3xTg-AD Mice , 2011, PloS one.

[74]  P. Calder,et al.  Dose-related effects of eicosapentaenoic acid on innate immune function in healthy humans: a comparison of young and older men. , 2006, The American journal of clinical nutrition.

[75]  Takashi Morihara,et al.  Docosahexaenoic Acid Protects from Dendritic Pathology in an Alzheimer's Disease Mouse Model , 2004, Neuron.

[76]  K. Su,et al.  Docosahexaenoic Acid Suppresses Neuroinflammatory Responses and Induces Heme Oxygenase-1 Expression in BV-2 Microglia: Implications of Antidepressant Effects for Omega-3 Fatty Acids , 2010, Neuropsychopharmacology.

[77]  G. Schmitz,et al.  The opposing effects of n-3 and n-6 fatty acids. , 2008, Progress in lipid research.

[78]  Victoria J. Bourne,et al.  n–3 Fatty acid erythrocyte membrane content, APOE ε4, and cognitive variation: an observational follow-up study in late adulthood , 2008 .

[79]  G. Cole,et al.  DHA may prevent age-related dementia. , 2010, The Journal of nutrition.

[80]  A. Hofman,et al.  Dietary fat intake and the risk of incident dementia in the Rotterdam study , 1997, Annals of neurology.

[81]  Zhe Ying,et al.  Exercise contributes to the effects of DHA dietary supplementation by acting on membrane-related synaptic systems , 2010, Brain Research.

[82]  P. Dederen,et al.  DHA and cholesterol containing diets influence Alzheimer-like pathology, cognition and cerebral vasculature in APPswe/PS1dE9 mice , 2009, Neurobiology of Disease.

[83]  Takashi Morihara,et al.  Dietary n‐3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer's disease , 2005, The European journal of neuroscience.

[84]  G. Schrauzer,et al.  Selenium and Alzheimer's disease: a systematic review. , 2011, Journal of Alzheimer's disease : JAD.

[85]  M. Piciotti,et al.  Delta 6 desaturase in brain and liver during development and aging. , 1990, Lipids.

[86]  M. Hallett,et al.  Imaging Neuroinflammation in Alzheimer's Disease with Radiolabeled Arachidonic Acid and PET , 2008, Journal of Nuclear Medicine.

[87]  A. Beekman,et al.  Effect of fish oil on cognitive performance in older subjects , 2008, Neurology.

[88]  A. Simopoulos,et al.  Common purslane: a source of omega-3 fatty acids and antioxidants. , 1992, Journal of the American College of Nutrition.

[89]  A. Drewnowski,et al.  The nutrition transition: new trends in the global diet. , 2009, Nutrition reviews.

[90]  J. Beer,et al.  High &ohgr;-3 Fatty Acid Content in Alpine Cheese: The Basis for an Alpine Paradox , 2003, Circulation.

[91]  S. Bandinelli,et al.  Low plasma N-3 fatty acids and dementia in older persons: the InCHIANTI study. , 2007, The journals of gerontology. Series A, Biological sciences and medical sciences.

[92]  J. Dyerberg,et al.  Fatty acid composition of the plasma lipids in Greenland Eskimos. , 1975, The American journal of clinical nutrition.

[93]  G. D. Paolo,et al.  Linking lipids to Alzheimer's disease: cholesterol and beyond , 2011, Nature Reviews Cancer.

[94]  R. Basha,et al.  The Fetal Basis of Amyloidogenesis: Exposure to Lead and Latent Overexpression of Amyloid Precursor Protein and β-Amyloid in the Aging Brain , 2005, The Journal of Neuroscience.

[95]  J. Buckley,et al.  Erythrocyte polyunsaturated fatty acid status, memory, cognition and mood in older adults with mild cognitive impairment and healthy controls. , 2011, Prostaglandins, leukotrienes, and essential fatty acids.

[96]  J. Lah,et al.  DHA diet reduces AD pathology in young APPswe/PS1ΔE9 transgenic mice: Possible gender effects , 2009, Journal of neuroscience research.

[97]  Michael Weiner,et al.  Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. , 2010, JAMA.

[98]  P. Aisen,et al.  Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain , 1998, Neuroscience.

[99]  R. Wade,et al.  Hypermethylation of Fads2 and Altered Hepatic Fatty Acid and Phospholipid Metabolism in Mice with Hyperhomocysteinemia* , 2007, Journal of Biological Chemistry.

[100]  F. Calon,et al.  High-fat diet aggravates amyloid-beta and tau pathologies in the 3xTg-AD mouse model , 2010, Neurobiology of Aging.

[101]  D. Le Gall,et al.  Fish consumption and dementia: keep the vitamin D in memory , 2010, European journal of neurology.

[102]  Artemis P. Simopoulos,et al.  Evolutionary Aspects of Diet: The Omega-6/Omega-3 Ratio and the Brain , 2011, Molecular Neurobiology.

[103]  M. Moghadasian,et al.  Advances in Dietary Enrichment with N-3 Fatty Acids , 2008, Critical reviews in food science and nutrition.

[104]  B. Popkin,et al.  A new stage of the nutrition transition in China , 2002, Public Health Nutrition.

[105]  Michio Hashimoto,et al.  DOCOSAHEXAENOIC ACID‐INDUCED PROTECTIVE EFFECT AGAINST IMPAIRED LEARNING IN AMYLOID β‐INFUSED RATS IS ASSOCIATED WITH INCREASED SYNAPTOSOMAL MEMBRANE FLUIDITY , 2006, Clinical and experimental pharmacology & physiology.

[106]  B. Meyer,et al.  Dietary intakes and food sources of omega-6 and omega-3 polyunsaturated fatty acids , 2003, Lipids.

[107]  M. Farlow,et al.  Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease Published, JLR Papers in Press, February 16, 2005. DOI 10.1194/jlr.M400486-JLR200 , 2005, Journal of Lipid Research.

[108]  H. Tanila,et al.  Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice , 2006, Neurobiology of Disease.

[109]  G. Burr,et al.  ON THE NATURE AND RÔLE OF THE FATTY ACIDS ESSENTIAL IN NUTRITION , 1930 .